水仙直播 awarded 拢1m PACE funding to progress uUTI treatment
As part of company鈥檚 tRNA synthetase development in oncology and infections聽 水仙直播 has been awarded 拢1m in funding to progress […]
水仙直播 achieves further in vivo validation of novel approach against multiple tumours
水仙直播, the 水仙直播-based AI drug discovery company, has announced today additional in vivo validation for its first-in-class approach against cancer […]
水仙直播 awarded share of 拢3m Cystic Fibrosis Collaborative Drug Discovery Programme
The cross-sector initiative provides funding and support to accelerate new treatments for lung infections in Cystic Fibrosis September 26th 2024, United Kingdom: […]